Prevention of D sensitization after mismatched transfusion of blood components: Toward optimal use of RhIG

Transfusion

Volumn 48, Issue 9, 2008, Pages 1990-1999

  Ayache, Saleh ^a   Herman, Jay H ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DIPHENHYDRAMINE; HYDROCORTISONE; HYPERRHO; IMMUNOGLOBULIN; PARACETAMOL; PREDNISOLONE; RHESUS D ANTIBODY; RHESUS D ANTIGEN; RHOPHYLAC; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; BLOOD GROUP RH; BLOOD TRANSFUSION REACTION; CHILL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEADACHE; HEMATURIA; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVASCULAR HEMOLYSIS; KIDNEY FAILURE; MALE; NAUSEA; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW; RHESUS INCOMPATIBILITY; RHESUS ISOIMMUNIZATION; SHIVERING; SIDE EFFECT; SKIN COLOR; VOMITING;

BLOOD COMPONENT TRANSFUSION; HUMANS; ISOANTIBODIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 50849084107     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01800.x     Document Type: Review

References (68)

1. Bowman JM, Chown B. Prevention of Rh immunization after massive Rh-positive transfusion. Can Med Assoc J 1968 99 : 385 8.
2. Phillips NE, Parker DC. Cross-linking of B lymphocyte Fcγ receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol 1984 132 : 627 32.
3. Ashman RF, Peckham D, Stunz LL. Fc receptor off-signal in the B cell involves apoptosis. J Immunol 1996 157 : 5 11.
4. Sato K, Ochi A. Superclustering of B cell receptor and FcγRIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1. J Immunol 1998 161 : 2716 22.
5. Kumpel BM, Goodrick MJ, Pamphilon DH, Fraser ID, Poole GD, Morse C, Standen GR, Chapman GE, Thomas DP, Anstee DJ. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D-volunteers. Blood 1995 86 : 1701 9.
6. Hughes-Jones NC. The estimation of the concentration and equilibrium constant of anti-D. Immunology 1967 12 : 565 71.
7. Jones NC, Mollison PL, Veall N. Removal of incompatible cells by the spleen. Br J Haematol 1957 3 : 125 33.
8. Frohn C, Dumbgen L, Brand JM, Gorg S, Luhm J, Kirchner H. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003 43 : 893 8.
9. Pollack W, Ascari WQ, Crispen JF, O'Connor RR, Ho TY. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh positive blood. Transfusion 1971 11 : 340 4.
10. Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981 21 : 64 9.
11. Gunson HH, Stratton F, Cooper DG, Rawlinson VI. Primary immunization of Rh-negative volunteers. BMJ 1970 1 : 593 5.
12. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972 23 : 376 81.
13. Yazer MH, Triulzi DJ. Detection of anti-D in D-recipients transfused with D+ red blood cells. Transfusion 2007 47 : 2197 201.
14. Bowman JM, Pollock JM. Reversal of Rh alloimmunization. Fact or fancy? Vox Sang 1984 47 : 209 15.
15. de Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh responses. Vox Sang 1985 48 : 178 80.
16. The Royal College of Obstetricians and Gynecologists. Use of anti-D immunoglobulin for Rh prophylaxis. London : Royal College of Obstetricians and Gynaecologists 1999. Revised May 2002. Available from http://www.rcog.org.uk/ index.asp?PageID=1972
17. Parker J, Wray J, Gooch A, Robson S, Qureshi H for the British Committee for Standards in Haematology. Guidelines for the use of anti-D immunoglobulin for Rh prophylaxis 2006. London : British Committee for Standards in Haematology 2008. Available from http://www.bcshguidelines.org/pdf/Anti-D_070606.pdf
18. Clarke CA, Donohoe WT, McConnell RB, Woodrow JC, Finn R, Jr K, Kulke W, Lehane D, Sheppard PM. Further experimental studies on the prevention of Rh haemolytic disease. BMJ 1963 1 : 979 84.
19. Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma A2-globulin antibody preparation: a preliminary report. Transfusion 1964 4 : 26 32.
20. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine, 9th ed. Oxford : Blackwell Scientific Publications 1993. p. 243.
21. Keith L, Cuva A, Houser K, Webster A. Suppression of primary Rh-immunization by anti-Rh. Transfusion 1970 10 : 142 7.
22. Keith L. Anti-Rh therapy after transfusion. J Reprod Med 1972 8 : 293 8.
23. Keith LG, Hauser GH. Anti Rh immune globulin after a massive transfusion accident. Transfusion 1971 11 : 176.
24. McElrath TG, Ascari WQ. Prevention of Rh immunization after transfusion with Rh positive blood. Am J Obstet Gynec 1971 110 : 309 11.
25. Pollack W, Ascari WQ, Kochesky RJ, O'Connor RR, Ho TY, Tripodi D. Studies on Rh prophylaxis. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971 11 : 333 9.
26. Samson D, Mollison PL. Effect on primary Rh immunization of delayed administration of anti-Rh. Immunology 1975 28 : 349 57.
27. Stucki M, Moudry R, Kempf C, Omar A, Schlegel A, Lerch PG. Characterisation of a chromatographically produced anti-D immunoglobulin product. J Chromatogr B Biomed Sci Appl 1997 700 : 241 8.
28. Bowman JM, Friesen AD, Pollock JM, Taylor WE. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. CMAJ 1980 123 : 1121 5.
29. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003 43 : 1661 6.
30. Bichler J, Schondorfer G, Pabst G, Andresen I. Pharmacokinetics of anti-D IgG in pregnant RhD-negative women. BJOG 2003 110 : 39 45.
31. Jouvenceaux A. Prevention of anti-Rh immunization. Rev Fr Transfus 1971 14 : 39 52.
32. Huchet J, Cregut R, Pinon F. Anti-D immunoglobulins. Comparative effectiveness of intra-muscular and intravenous routes. Rev Fr Transfus 1970 13 : 231 42.
33. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine, 9th ed. Oxford : Blackwell Scientific Publications 1993. p. 245.
34. Wegmann A, Hubner H, Erb H. Intravenous administration of anti-D hyperimmunoglobulin after mismatched transfusion [author's transl]. Dtsch Med Wochenschr 1976 101 : 1354 6.
35. Mollison PL. Blood transfusion in clinical medicine, 7th ed. Oxford : Blackwell Scientific Publications 1983. p. 385.
36. Lee D, Contreras M, Robson SC, Rodeck CH, Whittle MJ. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfus Med 1999 9 : 93 7.
37. British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Hematol 2003 120 : 574 96.
38. Anderson B, Shad AT, Gootenberg JE, Sandler SG. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol 1999 60 : 245 7.
39. Nester TA, Rumsey DM, Howell CC, Gilligan DM, Drachman JG, Maier RV, Kyles DM, Matthews DC, Pendergrass TW. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin. Transfusion 2004 44 : 1720 3.
40. Laspina S, O'Riordan JM, Lawlor E, Murphy WG. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin. Vox Sang 2005 89 : 49 51.
41. Ramsey G, Hahn LF, Cornell FW, Boczkowski DJ, Staschak S, Clark R, Hardesty RL, Griffith BP, Starzl TE. Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989 47 : 993 5.
42. Blomqvist BI, Wikman A, Shanwell A, Eleborg L. Erythrocyte antibodies in liver transplantation: experiences from Huddinge University Hospital. Transplant Proc 1991 23 : 1944 5.
43. Casanueva M, Valdes MD, Ribera MC. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994 34 : 570 2.
44. Boctor FN, Ali NM, Mohandas K, Uehlinger J. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003 43 : 173 6.
45. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Blood 1996 88 : 3 40.
46. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 1991 77 : 1884 93.
47. Cines DB, McKenzie SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003 25 Suppl 1 : S52 56.
48. Salama A, Kiefel V, Amberg R, Mueller-Eckhardt C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho(D)). Blut 1984 49 : 29 35.
49. Salama A, Kiefel V, Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986 22 : 241 50.
50. Baglin TP, Smith MP, Boughton BJ. Rapid and complete response of immune thrombocytopenic purpura to a single injection of rhesus anti-D immunoglobulin. Lancet 1986 1 : 1329 30.
51. Boughton BJ, Chakraverty R, Baglin TP, Simpson A, Galvin G, Rose P, Rohlova B. The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action. Clin Lab Haematol 1988 10 : 275 84.
52. Panzer S, Grumayer ER, Haas OA, Niessner H, Graninger W. Efficacy of rhesus antibodies (anti-Rho(D)) in auto-immune thrombocytopenia: correlation with response to high dose IgG and the degree of haemolysis. Blut 1985 52 : 117 21.
53. Gringeri A, Cattaneo M, Santagostino E, Mannucci PM. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 1992 80 : 337 40.
54. Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997 89 : 2689 700.
55. Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ. Acute ITP Study Group. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 2006 148 : 489 94.
56. Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg/kg/d of I.V. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001 112 : 1076 8.
57. O(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005 106 : 1532 7.
58. O(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000 95 : 2523 9.
59. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia. J Pediatr Hematol Oncol 2007 29 : 636 9.
60. Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions - risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971 284 : 942 4.
61. Baldwin ML, Ness PM, Scott D, Braine H, Kickler TS. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988 28 : 330 3.
62. McLeod BC, Piehl MR, Sassetti RJ. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sang 1990 59 : 185 9.
63. Menitove JE. Immunoprophylaxis for D-patients receiving platelet transfusions from D+ donors? Transfusion 2002 42 : 136 8.
64. Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000 111 : 980 3.
65. Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D-pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002 42 : 177 82.
66. Cid J, Ortin X, Elies E, Castella D, Panades M, Martin-Vega C. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002 42 : 173 6.
67. Abou-Elella AA, Camarillo TA, Allen MB, Barclay S, Pierce JA, Holland HK, Wingard JR, Bray RA, Rodey GE, Hillyer CD. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995 35 : 931 5.
68. Haspel RL, Walsh L, Sloan SR. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Transfusion 2004 44 : 747 9.